About Baxter Pharmaceuticals India Private Limited
Data last updated:
Baxter Pharmaceuticals India Private Limited is a private limited company based in Vasana Chacharwadi, Gujarat, India, a subsidiary of Baxter Pharmaceutical (Asia) Pte. Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 June 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2005PTC046211. Its GSTIN is 24AACCC6252B1Z8 (Gujarat).
The company has an authorised share capital of ₹2,000 Cr and a paid-up capital of ₹5.73 Lakh. It was formerly known as Claris Injectables Limited and Claris Lifesciences International Limited. It is led by directors including Sanju Dhawan and Anuranjan Naresh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village : Vasana – Chacharwadi Tal : Sanand, Vasana Chacharwadi, Gujarat, India – 382213.
As per the financials filed for FY 2025, the company reported a revenue of ₹671.53 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹16.49 Cr (net margin 2.5%) and EBITDA of ₹98.59 Cr (EBITDA margin 14.7%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 4% over five years.
The company has about 1,179 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Baxter. As per MCA filings, the company has open charges of ₹5 Cr and satisfied charges of ₹1,130.21 Cr on record. Court records list 20 cases involving the company, including 9 filed by the company and 11 filed against it; 11 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1,006.95 Cr; the latest was in March 2024. Its 9 peer companies in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Franco-Indian Pharmaceuticals Private Limited with revenue of ₹988.53 Cr. The company has 15 MSME Form 1 returns on record between 2019 and 2024, listing 698 overdue payments to 108 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website baxter.in.
Company details
Name history
Baxter Pharmaceuticals India has undergone 6 name changes throughout its history. The current legal name is Baxter Pharmaceuticals India Private Limited.
| Company Name | Status |
|---|---|
| Baxter Pharmaceuticals India Private Limited | Current |
| Claris Injectables Limited | Previous |
| Claris Lifesciences International Limited | Previous |
| Baxter Pharmaceutical India Private Limited | Previous |
| Claris International Limited | Previous |
| Claris Injectables Private Limited | Previous |
CIN history
Baxter Pharmaceuticals India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230GJ2005PTC046211, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ2005PTC046211 | Current |
| U24230GJ2005PLC046211 | Previous |
| U21009GJ2005PTC046211 | Previous |
Contact details
Baxter Pharmaceuticals India Private Limited's registered office is in Vasana Chacharwadi, Gujarat. Its website is baxter.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressVillage : Vasana – Chacharwadi Tal : Sanand, Vasana Chacharwadi, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Baxter Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Baxter Pharmaceuticals India operates one associated brand: Baxter. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biosciences, medication delivery, and renal products are developed and marketed. | baxter.com |
Business activity
The main business activity of Baxter Pharmaceuticals India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Baxter Pharmaceuticals India Private Limited, buy the company report.
Financials of Baxter Pharmaceuticals India Private Limited
FY 2025 filings availableBaxter Pharmaceuticals India Private Limited reported revenue of ₹671.53 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 20% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 218% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹98.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.49 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.7% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Baxter Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Baxter Pharmaceuticals India Private Limited
Baxter Pharmaceuticals India has 6 current directors and 26 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanju Dhawan | Director | 09 Jul 2021 | 5 Years 3 Months | Current |
| Anuranjan Naresh Also directs: Baxter India Private Limited, Hill-Rom India Private Limited | Additional Director | 01 Oct 2024 | 2 Years 0 Months | Current |
| Tripti Sapra Also directs: Baxter India Private Limited | Additional Director | 01 Oct 2024 | 2 Years 0 Months | Current |
| Ashwin Prakash Upasane | Additional Director | 18 Jun 2025 | 1 Years 4 Months | Current |
| Anurag Bharatkumar Pachchigar | Additional Director | 01 Oct 2024 | 2 Years 0 Months | Current |
| Gurjeet Singh Bedi | Additional Director | 23 Dec 2024 | 1 Years 10 Months | Current |
Peer comparison
Baxter Pharmaceuticals India Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Franco-Indian Pharmaceuticals Private Limited | ₹988.53 Cr (FY 2024) | 0.0% | Mumbai, Maharashtra, India | |||
| Synokem Pharmaceuticals Limited | ₹791.15 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| SMS Pharmaceuticals Limited | ₹788.97 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| Prime Pharmaceuticals Private Limited | ₹783.06 Cr (FY 2025) | 131.0% | Mumbai, Maharashtra, India | |||
| Wallace Pharmaceuticals Private Limited | ₹673.06 Cr (FY 2025) | 16.0% | Goa, India | |||
| Baxter Pharmaceuticals India Private Limitedthis company | ₹671.53 Cr (FY 2025) | ₹16.49 Cr | 2.5% | 20.0% | 1,179 | Vasana Chacharwadi, Gujarat, India |
| Lincoln Pharmaceuticals Ltd | ₹645.71 Cr (FY 2025) | 5.0% | Ahmedabad, Gujarat, India | |||
| Theon Pharmaceuticals Limited | ₹633.1 Cr (FY 2025) | 4.0% | Chandigarh, India | |||
| Malladi Drugs and Pharmaceuticals Limited | ₹626.79 Cr (FY 2025) | -7.0% | Chennai, Tamil Nadu, India | |||
| Sri Krishna Pharmaceuticals Limited | ₹608.24 Cr (FY 2025) | -13.0% | Telangana, India |
To see the full peer comparison of Baxter Pharmaceuticals India Private Limited, buy the company report.
Auditor
Baxter Pharmaceuticals India Private Limited is audited by Price Waterhouse & Co Chartered Accountants LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse & Co Chartered Accountants LLP | FY 2024 | 304026E/E-300009 |
Shareholding
The shareholding of Baxter Pharmaceuticals India Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Baxter Pharmaceuticals India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jul 2019 | 100285274 | Uco Bank | ₹5 Cr | Open | |
| 29 Mar 2016 | 100023480 | Others | ₹11.77 Lakh | Satisfied | |
| 19 Sep 2015 | 100027726 | Others | ₹7 Lakh | Satisfied | |
| 18 Sep 2015 | 100027727 | Others | ₹10 Lakh | Satisfied | |
| 31 Oct 2014 | 10528638 | Canara Bank | ₹564.96 Cr | Satisfied |
To see the full charge records of Baxter Pharmaceuticals India Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Baxter Pharmaceuticals India Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1,006.95 Cr; the latest was in March 2024.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Seller: Baxter Pharmaceutical (Asia) Pte Limited |
| Jul 2017 | Funding round | ₹522.95 Cr | Investors: Baxter Pharmaceutical (Asia) Pte Limited, Baxter Pharmaceutical (Asia) Pte Limited & Ravinder Pal Singh Dang, Baxter Pharmaceutical (Asia) Pte Limited & Shweta Dewan |
| Jul 2017 | Secondary share transfer | Undisclosed | Buyer: Baxter Pharmaceutical (Asia) Pte Limited Seller: Claris Lifesciences Limited |
| Jul 2017 | Secondary share transfer | Undisclosed | Buyer: Baxter Pharmaceutical (Asia) Pte Limited Seller: Claris Lifesciences Limited & Kirti Amrutlal Shah, Claris Lifesciences Limited & Chandan Shivrambhai Purohit, Claris Lifesciences Limited & Nirav Mehta |
| Jul 2017 | Secondary share transfer | Undisclosed | Seller: Claris Lifesciences Limited |
To see the full deal history of Baxter Pharmaceuticals India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Baxter Pharmaceuticals India Private Limited has 20 court cases on record: 9 filed by Baxter Pharmaceuticals India, 11 filed against it. 11 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 7 | 7 |
| High courts | 8 | 1 | 4 |
| Supreme Court | 3 | 3 | 0 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed against the company by Ahmedabad and 1 other | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against , Ahmedabad and 2 others | Disposed |
| High Court of Gujarat | Special civil application | Filed against the company by an individual | Pending |
| High Court of Gujarat | Special civil application | Filed by the company against Assistant Commissioner of Income Tax, Circle 1(1)(1), Ahmedabad | Pending |
| High Court, GUJARAT | Special civil application | Filed by the company against individuals | Pending |
To see the full case history of Baxter Pharmaceuticals India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Baxter Pharmaceuticals India Private Limited has 15 MSME Form 1 returns on record between 2019 and 2024, listing 698 overdue payments to 108 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 108)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Environomics Projects LLP | |||
| Biolinx Labsystems Private Limited | |||
| Sunny Sterile Products | |||
| Aakar Containers Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Baxter Pharmaceuticals India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Baxter Pharmaceuticals India Private Limited has a workforce of 1,179 employees on its EPFO records as of Oct 31, 2025, across 1 active EPFO establishment.
GST
Baxter Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCC6252B1Z8 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Baxter Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Baxter Pharmaceuticals India Private Limited has 33 board changes on record since 2008: 9 appointments and 24 cessations. The latest: Ashwin Prakash Upasane was appointed as Additional Director on 18 Jun 2025.
37 earlier events are in the company report.
News
Frequently asked questions
Baxter Pharmaceuticals India is an active private limited company based in Vasana Chacharwadi, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 June 2005 (21+ years old) and is registered under CIN U24230GJ2005PTC046211.
Baxter Pharmaceuticals India has 6 current directors:
- Sanju Dhawan - Director
- Anuranjan Naresh - Additional Director
- Tripti Sapra - Additional Director
- Ashwin Prakash Upasane - Additional Director
- Anurag Bharatkumar Pachchigar - Additional Director
- Gurjeet Singh Bedi - Additional Director
The latest financial statements of Baxter Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Baxter Pharmaceuticals India is 24AACCC6252B1Z8, registered in Gujarat.
The CIN (Corporate Identification Number) of Baxter Pharmaceuticals India is U24230GJ2005PTC046211. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Baxter Pharmaceuticals India has 20 court cases on record: 9 filed by the company and 11 filed against it. 11 are pending. Most are in the district courts.
Baxter Pharmaceuticals India was incorporated on 08 June 2005, making it 21+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Baxter Pharmaceuticals India has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1,006.95 Cr; the latest was in March 2024.
The peers of Baxter Pharmaceuticals India by revenue are Franco-Indian Pharmaceuticals Private Limited, Synokem Pharmaceuticals Limited, SMS Pharmaceuticals Limited, Prime Pharmaceuticals Private Limited, Wallace Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashwin Prakash Upasane was appointed as Additional Director on 18 Jun 2025. Gurjeet Singh Bedi was appointed as Additional Director on 23 Dec 2024. Anurag Bharatkumar Pachchigar was appointed as Additional Director on 01 Oct 2024. Baxter Pharmaceuticals India has 33 board changes on record in total.
Baxter Pharmaceuticals India has 15 MSME Form 1 returns on record between 2019 and 2024, listing 698 overdue payments to 108 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Baxter Pharmaceuticals India can be reached through the website baxter.in. Its registered office is in Vasana Chacharwadi, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
